Status:
COMPLETED
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Polycystic Ovary Syndrome
Infertility, Female
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
The study is conducted at Arash Women's Hospital on all women undergoing the frozen embryo transfer cycle. Patients who signed informed consent will be randomly divided into two groups. The first grou...
Eligibility Criteria
Inclusion
- The first or second cycle of embryo transfer Normal uterine cavity PCO diagnosis based on Rotterdam criteria and correction (2018) Age 20 to 40 years
Exclusion
- Infertility with severe male factor endometriosis immunological disease FSH higher than 10 BMI greater than or equal to 30 Endometrial thickness on the day of transfer is less than 7 mm History of recurrent miscarriage
Key Trial Info
Start Date :
June 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2022
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT05189873
Start Date
June 10 2021
End Date
January 3 2022
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arash women's hospital,Tehran university of medical sciences
Tehran, Iran, 1653915981